The best craving & weight-management supplements of 2026, ranked

The most transparent standalone GLP-1 capsule: fully-disclosed branded actives in a simple once-daily pill, though it covers fewer hunger pathways than the Ozzi capsule.

Why it ranks third: Three standardized plant extracts the brand says work together to support the body’s own GLP-1 production, reduce hunger and cravings, and support healthy weight management. Lemme states it is not GLP-1, not synthetic GLP-1, and not a GLP-1 drug. Its strongest axis is ingredient transparency & quality (4/5). Each branded ingredient (Eriomin, Supresa, Morosil) has its own supplier-cited human studies, but there is no published RCT on this specific three-ingredient combination; efficacy rests on individual-ingredient research.

Best Value: cheap, drinkable, and well-evidenced as a fiber — but single-pathway and a heavy gel load.

Why it ranks fourth: Psyllium husk is a gel-forming soluble fiber that absorbs water to form a viscous gel, which the brand says promotes fullness, supports regularity, and helps maintain healthy blood sugar and cholesterol already in the normal range. Its strongest axis is price & value (5/5). Psyllium has reasonably strong human RCT evidence for cholesterol lowering, glycemic response, and regularity, and moderate evidence for short-term satiety; the strongest claims are digestive rather than weight loss.

A cheap, no-frills berberine — same evidence, same berberine tolerability problem.

Why it ranks fifth: Berberine positioned to support healthy glucose metabolism already in the normal range, delivered in a softgel with MCT oil intended to improve absorption. Its strongest axis is ingredient transparency & quality (4/5). Berberine itself has human RCT support for glucose and lipid markers; the MCT-oil delivery benefit is a brand rationale with limited independent confirmation. (Despite some listings, this product is berberine + MCT, not berberine + ALA.)

Well-evidenced berberine for metabolic support — but the effective dose is rough on a lot of stomachs.

Why it ranks sixth: Berberine is a plant alkaloid the brand says supports healthy glucose and lipid metabolism, partly via the AMPK energy-sensing pathway, with the phytosome form intended to improve absorption. Its strongest axis is ingredient transparency & quality (4/5). Berberine has multiple human RCTs and meta-analyses for fasting glucose, HbA1c, and lipids; absorption is naturally poor (the rationale for the phytosome). The casual "nature’s Ozempic" label is not supported by head-to-head GLP-1 drug trials.

The best-evidenced single-mechanism appetite trigger — clinically interesting, but premium-priced and a pre-meal, short-window tool rather than all-day support.

Why it ranks seventh: Calocurb is built around Amarasate, a patented bitter hops-flower extract. Its bitter compounds activate bitter taste receptors (TAS2Rs) in the gut, triggering release of the appetite-regulating hormones GLP-1, CCK, and PYY — the same gut-hormone axis the GLP-1 conversation centers on — to blunt hunger before a meal. Its strongest axis is ingredient transparency & quality (4/5). Amarasate has more direct human appetite-trial data than most ingredients in this category: randomized, double-blind, crossover studies report roughly 10–30% lower hunger and about 18% lower calorie intake at a meal. Two honest caveats — the effect is acute (a 1–2 hour pre-meal window, not all-day support), and most of the strongest research is funded by or connected to the ingredient’s owner (Plant & Food Research / Calocurb).

A drinkable, gut-first option — but it leans on a proprietary fiber blend and a heavy fiber load.

Why it ranks eighth: A blend of soluble, insoluble, and resistant prebiotic fibers (6–7 g total per serving) marketed to nourish beneficial gut bacteria and support the body’s natural GLP-1 activity, promoting satiety and curbing cravings. Its strongest axis is hunger-pathway coverage (4/5). Brand cites a foundational pilot and an observational study partly relying on self-reported data; the individual fibers have supportive research, but evidence specifically validating this finished product’s GLP-1/appetite claims is limited and largely brand-sponsored.

Strong science pedigree on Akkermansia, but a proprietary CFU blend and refrigeration requirement.

Why it ranks ninth: Probiotic strains described as producing short-chain-fatty-acid postbiotics (butyrate, propionate, acetate) and the metabolite p9 in the gut, which the brand says supports the body’s own GLP-1 signaling and satiety. Its strongest axis is mechanism & science (4/5). Akkermansia muciniphila has human and preclinical research linking it to metabolic and GLP-1 pathways, but there is no published RCT showing this consumer formula causes weight loss or measurable GLP-1 increases.

A maximal glucomannan dose — which is also its risk: top-of-range fiber means you must take it carefully with plenty of water.

Why it ranks tenth: Built around glucomannan, a viscous soluble fiber that absorbs water and expands in the stomach to promote fullness, paired with B-vitamins, choline, chromium, and plant extracts marketed to support normal metabolism. Its strongest axis is ingredient transparency & quality (4/5). Glucomannan has human RCT data and an EU/EFSA satiety claim at 3 g/day, though a 2014 meta-analysis found no significant weight loss; the green coffee, acai, and B-vitamin additions are largely preclinical or under-dosed.

Best for Daytime Energy: a caffeinated daytime option for some — but useless for after-dinner cravings, and it hides its doses.

Why it ranks #11: Marketed to support weight management across several pathways at once — thermogenesis and fat metabolism, appetite/craving control, energy, and mood — as a daily structure/function supplement. Its strongest axis is hunger-pathway coverage (3/5). Marketing cites a manufacturer-sponsored study on the branded a-Lacys Reset blend rather than independent RCTs on the finished product; most actives are hidden in proprietary blends.

A cheap stimulant thermogenic — daytime energy only, with weak weight-management evidence.

Why it ranks #12: A caffeine-anhydrous-based thermogenic the brand says supports energy, focus, and metabolism, with C. canephora robusta marketed as a weight-management ingredient. Its strongest axis is price & value (4/5). Caffeine has solid evidence for short-term energy/thermogenesis; the C. canephora weight-loss claim rests on small manufacturer-cited trials considered low-quality by independent reviewers.

Cheap single-ingredient glucomannan — fine as a fiber, but it does only one thing.

Why it ranks #13: A single-ingredient glucomannan capsule. The soluble fiber absorbs water and expands in the stomach to promote fullness; non-stimulant and caffeine-free. Its strongest axis is price & value (4/5). Glucomannan has some human support for modest satiety when taken before meals with water, but results are mixed and Lipozene’s marketing has drawn FTC scrutiny historically. Evidence is for the fiber generally, not this brand.